Immune globulin intravenous, sometimes referred to as "IGIV" or "IVIG," is also known as pooled human gamma globulin or, simply, gamma globulin. IGIV belongs to a group of medicines that work by affecting a patient's immune system. For decades IGIV has been used to treat a variety of infectious or inflammatory diseases, as well as for the treatment of a variety of autoimmune disorders. A doctor prescribes IGIV therapy.

  Canada
  Germany
  USA

Hyperimmune globulin therapy are concentrated immunoglobulins used to treat patients whose immune systems have been compromised. Constant monitoring in steps of the manufacturing and delivery process make these biological products safe, easy, and convenient to use. A doctor or healthcare provider prescribes hyperimmune globulin therapies.

  Canada
  USA

Antihemophilic factor is a concentrate containing factor VIII and IX-clotting factors that are used for treatment of persons with hemophilia. Hemophilia is a genetic disorder characterized by the deficiency or absence of one of the proteins (or factors) in blood plasma that is responsible for clotting. Low levels of one of these plasma proteins result in bleeding and difficulty clotting in the affected individual. The most common deficiencies of clotting proteins are factor VIII and factor IX. A doctor or healthcare provider prescribes antihemophilic therapies.

  USA

Human albumin is a protein manufactured by the liver. It performs multiple functions, including the transport of many small molecules in the blood. Albumin products are used to manage serious and often life-threatening conditions, such as shock and blood loss due to trauma, burns, and surgery. A doctor or healthcare provider prescribes albumin.

  Canada 
  USA

Alpha₁-antitrypsin (AAT) deficiency, also known as Alpha-1, is a genetic (inherited) disorder that causes significant reduction in the naturally occurring blood protein alpha₁-antitrypsin. A low level of alpha₁-antitrypsin allows certain enzymes to attack healthy tissues in the body, primarily in the lungs. To replace missing or reduced levels of AAT, physicians often prescribe "augmentation" therapy with an alpha₁-proteinase inhibitor.


  Canada 
  Germany
  USA

Antithrombin III (AT-III) is a blood protein that inhibits or stops the clotting factors in blood. Approximately 75% of the body's plasma coagulation inhibitory activity is derived from AT-III. AT-III deficiency is a rare inherited or spontaneously occurring condition that affects 1 in every 2,000 to 5,000 males and females worldwide. Individuals with the condition lack the AT-III protein and spontaneous clotting can occur as a result of normal, daily activity. A doctor or healthcare provider prescribes Antithrombin III.

 USA